Literature DB >> 24442321

Electrophysiologic evaluation of retinal function in patients with psoriasis and vitiligo.

Nasser Shoeibi1, Ahmad Reza Taheri, Malihe Nikandish, Arash Omidtabrizi, Nasim Khosravi.   

Abstract

PURPOSE: To investigate the relation between psoriasis and vitiligo with the electrophysiologic function of the retinal photoreceptors.
METHODS: Patients with psoriasis or vitiligo referred for PUVA therapy were enrolled. Complete eye examination was performed. Patients with any drug or familial history or abnormal eye examination that might affect the retinal function were excluded. Standardized full-field electroretinogram (ERG) elicited with Ganzfeld stimuli using the commercial ERG system (Retiport32; Roland Consult) according to International Society for Clinical Electrophysiology of Vision guidelines was performed. The outcome measures were the difference between the mean rod response, standard combined response, single-flash cone response and 30-Hz flicker wave amplitudes of the patients and normal population.
RESULTS: Seventy-six eyes of 38 patients (vitiligo: 21; psoriasis: 17) and 40 eyes of 20 normal subjects were enrolled in this study. The mean age of patients was 31.3 ± 11.3 years (range 16-54 years). Twenty-two patients (58 %) were female. The mean rod response b-wave, standard combined a- and b-waves, single-flash cone response b-wave and the 30-Hz flicker (N1-P1) amplitudes were significantly lower than the normal population in the same range of age as the study group. There was no significant difference between the patients with vitiligo and those with psoriasis in all wave amplitudes (P = 0.094).
CONCLUSION: This study showed that overall retinal electrophysiologic function in patients with vitiligo or psoriasis is significantly impaired compared with normal population, independent of age and sex.

Entities:  

Mesh:

Year:  2014        PMID: 24442321     DOI: 10.1007/s10633-014-9425-2

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  12 in total

1.  Central serous chorioretinopathy in patients with psoriasis.

Authors:  Carlo Nucci; Andrea Corsi; Raffaele Mancino; Giuseppe Macri
Journal:  Acta Ophthalmol Scand       Date:  2004-02

Review 2.  Ocular damage in patients with psoriasis treated by psoralen UV-A therapy or narrow band UVB therapy: a systematic literature review.

Authors:  E Archier; S Devaux; E Castela; A Gallini; F Aubin; M Le Maître; S Aractingi; H Bachelez; B Cribier; P Joly; D Jullien; L Misery; C Paul; J P Ortonne; M A Richard
Journal:  J Eur Acad Dermatol Venereol       Date:  2012-05       Impact factor: 6.166

3.  ISCEV Standard for full-field clinical electroretinography (2008 update).

Authors:  M F Marmor; A B Fulton; G E Holder; Y Miyake; M Brigell; M Bach
Journal:  Doc Ophthalmol       Date:  2008-11-22       Impact factor: 2.379

4.  ERG abnormalities in relation to histopathologic findings in vitiligo mutant mice.

Authors:  M Tang; B S Pawlyk; B Kosaras; E L Berson; R L Sidman
Journal:  Exp Eye Res       Date:  1997-08       Impact factor: 3.467

5.  Evidence of decreased adhesion between the neural retina and retinal pigmented epithelium of the Mitfvit (vitiligo) mutant mouse.

Authors:  N Bora; D Defoe; S B Smith
Journal:  Cell Tissue Res       Date:  1999-01       Impact factor: 5.249

Review 6.  Ocular psoriasis.

Authors:  Balvinder Rehal; Bobeck S Modjtahedi; Lawrence S Morse; Ivan R Schwab; Howard I Maibach
Journal:  J Am Acad Dermatol       Date:  2011-05-06       Impact factor: 11.527

7.  Vitiligo: ocular and electrophysiological findings.

Authors:  M Perossini; E Turio; T Perossini; G Cei; P Barachini
Journal:  G Ital Dermatol Venereol       Date:  2010-04       Impact factor: 2.011

8.  Clinical pattern of ocular manifestations in vitiligo.

Authors:  Gautam Biswas; Joyshree Nath Barbhuiya; Mukul Chandra Biswas; Md Nazarul Islam; Subrata Dutta
Journal:  J Indian Med Assoc       Date:  2003-08

9.  Vitiligo and disorders of the retinal pigment epithelium.

Authors:  D M Albert; M D Wagoner; R C Pruett; J J Nordlund; A B Lerner
Journal:  Br J Ophthalmol       Date:  1983-03       Impact factor: 4.638

10.  Reduced full-field electroretinogram (ERG) in a patient treated with methotrexate.

Authors:  Vesna Ponjavic; Lotta Gränse; Elisabeth Bengtsson Stigmar; Sten Andréasson
Journal:  Acta Ophthalmol Scand       Date:  2004-02
View more
  4 in total

1.  The assessment of macular electrophysiology and macular morphology in patients with vitiligo.

Authors:  Rukiye Aydin; Mustafa Ozsutcu; Sevil Karaman Erdur; Funda Dikkaya; Ali Balevi; Merve Ozbek; Fevzi Senturk
Journal:  Int Ophthalmol       Date:  2017-01-21       Impact factor: 2.031

2.  Assessment of the Effect of Vitiligo on Subfoveal Choroidal Thickness Using Spectral-Domain Optical Coherence Tomography.

Authors:  Yousef Ahmed Fouad; Abdelrahman Gaber Salman; Thanaa Helmy Mohamed; Randa Hesham Ali Abdelgawad; Samah Ibraheem Hassen
Journal:  Clin Ophthalmol       Date:  2020-08-11

3.  Dry Eye and Meibomian Glands in Vitiligo

Authors:  Ahmad Reza Taheri; Elahe Allahyari; Borhan Haghi Rudi; Malihe Nikandish
Journal:  Turk J Ophthalmol       Date:  2021-04-29

4.  Relationship between retinal sensitivity and disease activity in patients with psoriasis vulgaris.

Authors:  Helin Deniz Demir; Göknur Kalkan; Semiha Kurt; Alper Güneş; Engin Sezer; Ünal Erkorkmaz
Journal:  Clinics (Sao Paulo)       Date:  2015-01       Impact factor: 2.365

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.